Sector: MedicalTAROF (OTCBB: TAROF)
Headlines
- Taro sues Sun Pharma in US
Sep 30, 2009 06:24 PM | TAROF
- Taro Files Lawsuit against Sun in U.S. Federal Court
Sep 29, 2009 04:33 PM | TAROF
- Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer
Sep 14, 2009 11:01 AM | TAROF
- Taro Announces Postponement of September 13, 2009 Shareholders Meeting
Sep 11, 2009 11:33 AM | TAROF
- Sun Pharmaceutical Files HSR Application for Taro Tender Offer
Aug 28, 2009 10:06 AM | TAROF
- Hi-Tech Pharmacal: Hi-Growth at a Value Price
Jan 28, 2009 02:10 PM | HDIX, HITK, MRK, MYL, TAROF
- Beyond Stem Cells: Healthcare Hot Spots
Jan 26, 2009 02:14 PM | ABT, ACS, CBMX, DNA, ECLP
- Five Healthcare Stocks for a Happy New Year
Dec 23, 2008 09:32 AM | AMAG, AMGN, BBA, BDSI, CMC, CYPB
- Nine For '09: Stock Picks For The New Year
Dec 10, 2008 11:23 PM | AAPL, BBA, CELG, CMED, JAV, KFT
- Health Cost Containment Index: Expanding Into India, Impax Labs Set to Re-List
Nov 27, 2008 12:55 AM | ESRX, IPXL, MHS, MNTA, NVS, PRGO
- Taro Provides Preliminary First Half 2009 Financial Results
Aug 10, 2009 05:05 PM | TAROF
- Taro Sues Synerx Pharma, Karalex Pharma and DPT Laboratories for Patent Infringement
Jul 27, 2009 07:15 AM | TAROF
- Taro Receives FDA Approval for Cetirizine Hydrochloride Tablets (OTC) ANDA
Jul 27, 2009 07:01 AM | TAROF
- Taro Receives Patent for Ovide®
Jul 15, 2009 07:05 AM | TAROF
- Taro Receives Patent for Ovide(r)
Jul 15, 2009 07:01 AM | TAROF
- Taro Announces Preliminary Court Approval of Settlement in Securities Lawsuit
Jun 11, 2009 07:00 AM | TAROF
- Taro and Quinnova Announce Agreement to Co-Promote “Neosalus” and “Cleanse & Treat” in the United States
Jun 10, 2009 07:07 AM | TAROF
- Taro Receives FDA Approval for Sulfacetamide Sodium Topical Suspension ANDA
May 21, 2009 07:02 AM | TAROF
- Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets
Apr 03, 2009 08:27 AM | TAROF
- Taro Receives FDA Approval for Levetiracetam Oral Solution
Feb 11, 2009 07:02 AM | TAROF
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 22 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 23, 2009 08:30 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 16 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 20, 2009 08:49 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 15 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 16, 2009 08:54 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 14 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 15, 2009 02:32 PM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 13 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 14, 2009 08:08 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 12 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 13, 2009 08:40 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 09 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 12, 2009 08:40 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 08 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 09, 2009 09:16 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Jan 07 Filed by: FRANKLIN RESOURCES INC (10K)
Jan 08, 2009 09:13 AM
- Form 4 TARO PHARMACEUTICAL INDU For: Nov 13 Filed by: FRANKLIN RESOURCES INC (10K)
Nov 14, 2008 08:37 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
TAROF
|
Compare to S&P
|
| YTD |
20.13 %
|
-0.58 %
|
| 4 Weeks |
0.54 %
|
-0.54 %
|
| 12 Weeks |
1.54 %
|
-4.27 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 14.81 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 14.05 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
